Blood Purification Equipment Market Size, Share and Trends Forecast 2025-2033

# Blood Purification Equipment Market Size, Share and Trends Forecast 2025-2033 Market Overview: The Blood Purification Equipment Market is experiencing steady expansion, driven by Increasing Prevalence of Kidney Diseases, Technological Advancements in Blood Purification, and Increasing Demand for Critical Care Treatment. According to IMARC Group's latest research publication, "Blood Purification Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global <a href="https://www.imarcgroup.com/blood-purification-equipment-market">blood purification equipment market size</a> was valued at USD 22.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 36.7 Billion by 2033, exhibiting a CAGR of 5.76% during 2025-2033. This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis. Download a sample PDF of this report:<a href="https://www.imarcgroup.com/blood-purification-equipment-market/requestsample"> https://www.imarcgroup.com/blood-purification-equipment-market/requestsample</a> Our Report Includes: <ul> <li style="font-weight: 400;">Market Dynamics</li> <li style="font-weight: 400;">Market Trends and Outlook</li> <li style="font-weight: 400;">Competitive Analysis</li> <li style="font-weight: 400;">Industry Segmentation</li> <li style="font-weight: 400;">Strategic Recommendations</li> </ul> Growth Factors in the Blood Purification Equipment Market Industry: <ul> <li style="font-weight: 400;">Increasing Prevalence of Kidney Diseases</li> </ul> The surge in demand for blood purification equipment is primarily driven by the growing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). NCBI reports that CKD incidence and prevalence have risen by approximately 40% globally over the last thirty years. As impaired kidneys are unable to eliminate toxins effectively, more patients now rely on dialysis and similar blood-cleansing methods. Factors such as rising CKD cases, global health trends, increasing adoption of hemodialysis and hemofiltration systems, and a growing elderly population who are more vulnerable to kidney-related conditions are boosting market expansion. In response, manufacturers are consistently enhancing device safety, comfort, and efficiency for patient care. The healthcare infrastructure both in the developed and developing countries is expanding the dialysis infrastructure, thereby bringing this type of blood purification technology to a wider population base, that creates a positive market outlook for blood purification equipment. <ul> <li style="font-weight: 400;">Technological Advancements in Blood Purification</li> </ul> An additional prime factor catalyzing the market growth is the development of blood purification technologies at a higher level of advancement. Advancements in filtration and adsorption technologies have significantly improved the removal of toxins, immune complexes, and metabolic waste from the bloodstream. Modern systems like high-flux dialyzers and next-generation hemoperfusion cartridges offer enhanced treatment outcomes for patients with sepsis, autoimmune disorders, and multiple organ dysfunctions. As per the World Health Organization, sepsis contributed to 48.9 Million cases and 11 Million deaths globally in 2020—around 20% of all recorded deaths. The introduction of portable and wearable blood purification devices is enhancing patient mobility, especially for those requiring frequent sessions. These evolving solutions are expanding beyond traditional dialysis, enabling treatment for both acute and chronic conditions and creating broader opportunities for healthcare providers and device manufacturers. <ul> <li style="font-weight: 400;">Increasing Demand for Critical Care Treatment</li> </ul> The rising number of patients in need of intensive care, especially in ICUs, is fueling the expansion of the market. Recent studies show that global demand for critical care services has surged by 30–40%, largely due to the aging population, with individuals aged 65 and older making up nearly 60% of ICU admissions in developed nations. Life-threatening conditions such as sepsis, organ failure, and severe inflammation often require blood purification procedures to eliminate harmful agents and stabilize patients. The COVID-19 crisis further underscored the importance of these devices in managing serious complications. Increased recognition of extracorporeal blood purification's effectiveness in critical care, along with public healthcare investments aimed at upgrading ICU capabilities with advanced purification systems, is playing a major role in accelerating market growth. Key Trends in the Blood Purification Equipment Market: <ul> <li style="font-weight: 400;">Increasing Consumer Demand for Nutritious Snacks</li> </ul> The market for blood purification equipment is seeing a steady shift toward compact and portable devices. This is mainly due to the growing focus on home-based treatments and the need for flexible care options for patients with chronic illnesses. Portable units offer ease of use, quicker setup, and increased comfort for users, which is especially helpful for elderly patients or those requiring regular dialysis. These devices are becoming more advanced, with features that allow for efficient filtration without compromising on performance. Healthcare providers are also supporting this shift as portable models reduce patient load in hospitals and clinics. A notable development in 2024 was the launch of lightweight models with real-time monitoring features, enhancing safety during use at home. Manufacturers are also focusing on battery life improvements and user-friendly interfaces. The availability of remote support through connected apps is helping users manage treatment with minimal supervision. <ul> <li style="font-weight: 400;">Growing Preference for Plant-Based Protein Sources</li> </ul> The United States stands out as a key market disruptor, driven by the rapid adoption of cutting-edge technologies in blood purification systems and a strong focus on patient-centered care. Healthcare providers in the US are prioritizing efficiency, accuracy, and reduced treatment times, which has encouraged manufacturers to invest in smarter equipment with real-time monitoring and automated controls. The integration of AI-powered diagnostics, improved membrane technologies, and user-friendly interfaces is becoming more common across hospitals and outpatient dialysis centers. In 2024, multiple US-based firms introduced AI-assisted devices that automatically adapt purification cycles based on patient vitals, enhancing treatment precision and safety. There has also been a marked shift toward connectivity, with cloud-based data tracking now being used to manage patient records and device performance remotely. These innovations help clinicians make faster decisions while also supporting remote patient management an important feature as telehealth expands across the country. <ul> <li style="font-weight: 400;">Sustainable Farming and Organic Production</li> </ul> In 2024, the renal diseases segment led the blood purification equipment market, driven by the rising global burden of chronic kidney disease (CKD), diabetes, and hypertension-related complications. An increasing number of patients progressed to end-stage renal disease (ESRD), requiring long-term blood purification therapies such as hemodialysis and hemofiltration. Early diagnosis efforts and public screening programs expanded patient intake into treatment cycles. The need for effective toxin removal and fluid balance in renal patients heightened demand for advanced purification systems. Additionally, updated clinical guidelines and wider insurance coverage encouraged continuous therapy adoption. The renal disease segment thus became a consistent and high-volume demand source for such equipment. Leading Companies Operating in the Global Blood Purification Equipment Market Industry: <ul> <li style="font-weight: 400;">Aethlon Medical Inc.</li> <li style="font-weight: 400;">Asahi Kasei Corporation</li> <li style="font-weight: 400;">B. Braun Melsungen AG</li> <li style="font-weight: 400;">Baxter International Inc.</li> <li style="font-weight: 400;">Cerus Corporation</li> <li style="font-weight: 400;">CytoSorbents Corporation</li> <li style="font-weight: 400;">Fresenius SE & Co. KGaA</li> <li style="font-weight: 400;">Healthwell Medical Tech. Co. Ltd.</li> <li style="font-weight: 400;">Jafron Biomedical Co. Ltd.</li> <li style="font-weight: 400;">Kaneka Corporation</li> <li style="font-weight: 400;">Medtronic plc</li> <li style="font-weight: 400;">Nikkiso Co ltd.</li> <li style="font-weight: 400;">Spectral Medical Inc.</li> </ul> Blood Purification Equipment Market Report Segmentation: Breakup by Product Type: <ul> <li style="font-weight: 400;">Portable</li> <li style="font-weight: 400;">Stationary</li> </ul> Portable exhibited a clear dominance in the market due to growing demand for home-based and point-of-care treatments among patients with chronic illnesses. The convenience of compact, user-friendly machines enabled wider use beyond hospital settings, particularly for elderly and mobility-restricted individuals. Breakup by Indication: <ul> <li style="font-weight: 400;">Sepsis</li> <li style="font-weight: 400;">Renal Diseases</li> <li style="font-weight: 400;">Others</li> </ul> Renal Diseases exhibited a clear dominance in the market due to the rising global burden of chronic kidney disease (CKD), diabetes, and hypertension-related complications. An increasing number of patients progressed to end-stage renal disease (ESRD), requiring long-term blood purification therapies. Breakup by End User: <ul> <li style="font-weight: 400;">Hospitals and Clinics</li> <li style="font-weight: 400;">Dialysis Centers</li> <li style="font-weight: 400;">Others</li> </ul> Dialysis Centers exhibited a clear dominance in the market due to increasing investments in infrastructure, rising patient dependency on outpatient dialysis services, and the centralized management of chronic kidney treatments. Dialysis centers offered scalable care models with cost efficiencies, trained staff, and standardized protocols. Breakup by Region: <ul> <li style="font-weight: 400;">North America (United States, Canada)</li> <li style="font-weight: 400;">Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)</li> <li style="font-weight: 400;">Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)</li> <li style="font-weight: 400;">Latin America (Brazil, Mexico, Others)</li> <li style="font-weight: 400;">Middle East and Africa</li> </ul> Asia Pacific dominated the global market due to fast-paced urban development, a rising burden of chronic kidney and metabolic disorders, and expanding healthcare infrastructure. Countries such as China and India experienced higher dialysis demand due to the growing number of CKD cases and limited access to organ transplants. Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations. About Us: IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States:+1-201-971-6302